Facebook
Twitter
LinkedIn
ForwardPerinatal Neonatal Quality Improvement Network Fall Summit, 12/11/23
Claiming Credit for Session
Thank you for attending PNQIN's Fall Summit meeting on December 11, 2023. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
To communicate PNQIN quality improvement project updates with statewide perinatal teams and partner organizations. PNQIN’s current initiatives are focused on eliminating racial and ethnic inequities in maternal and neonatal outcomes.
Target Audience
PNQIN providers and professionals including nurses, nurse practitioners, physicians, certified nurse midwives, physician assistants, doulas, lactation consultants, patients, families, community members and organizations, peer recovery coaches, public health professionals, students, and social workers.
Learning Objectives
At the completion of this activity, pharmacists will be able to:
- Describe short- and long- term goals of the PNQIN and collaborator equity-focused projects.
- Identify available resources to help integrate mental health care best practices into obstetric care settings.
- Identify areas of maternal and neonatal care where racial and ethnic inequities exist.
- Describe the impact of mental health on perinatal populations.
- Demonstrate the approach and necessary process for operationalizing health equity within a healthcare system.
Faculty Presenters and Disclosures
Audra Meadows, MD, MPH, FACOG
Course Director
Obstetrician/Gynecologist
Co-Director
Perinatal Neonatal Quality Improvement Network of Massachusetts
The following speakers have no relevant financial relationships to disclose:
Kathleen Barker, Saba Berhie, Barbara Fain, Robert Goldstein, Erica Holland, Thea James, Cindy Liu, Audra Meadows, Megan Miller, Leena Mittal, Kate Murphy, Megan O'Brien, Godwin Osei-Poku, Jessica Paulino, Christin Price, Tiffany Moore Simas, Kate Standish, Abby Takesian.
Dr. Audra Meadows, course director and speaker, is a consultant for Ferring Pharmaceuticals.
Off-Label Discussion
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products.
Planning Committee and Disclosures
Beth Buxton, LCSW, Social Worker Accreditation Reviewer; Hafsatou Diop, MD, MPH; Bonnell Glass, RN, MN; BA; CNE Accreditation Reviewer; Audra Meadows, MD, MPH; Margert Parker, MD; Christin Price, MD; Aviel Peaceman, MPH; Caroline Somerville, Kali Vitek, MPH of PNQIN have no relevant financial relationships to disclose.
Accreditor Disclosures
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships to disclose:Michael Burk, BS – Operations Manager
Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
Off-Label Discussion
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products.
Joint Accreditation
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Perinatal Neonatal Quality Improvement Network (PNQIN). Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME Accreditation
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ANCC Accreditation
Contact Hours: 6.75, all of which is eligible for pharmacology credit.
Social Work Accreditation
As a Jointly Accredited Organization, Boston University Chobanian & Avedisian School of Medicine is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 6.75 clinical continuing education credits.
Risk Management
This program includes 6.75 hours which meet the criteria of the Massachusetts Board of Registration in Medicine for risk management study.
Available Credit
- 6.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.75 MA Risk Management
- 6.75 ANCC
- 6.75 ANCC Pharmacology
- 6.75 Social Work (ACE)
- 6.75 Participation